![Chris Coombe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Coombe
Finanzdirektor/CFO bei New Zealand Diagnostics Group Ltd.
Profil
Chris Coombe is currently the Chief Financial Officer at New Zealand Diagnostics Group Ltd.
He previously worked as the Manager-Marketing & Business Performance at Air New Zealand Ltd., and as a Principal at both ZESPRI International Ltd.
(United States) and eBonz Ltd.
Mr. Coombe obtained an undergraduate degree from Auckland University.
Aktive Positionen von Chris Coombe
Unternehmen | Position | Beginn |
---|---|---|
New Zealand Diagnostics Group Ltd.
![]() New Zealand Diagnostics Group Ltd. Medical/Nursing ServicesHealth Services Part of Healthscope Operations Pty Ltd., New Zealand Diagnostics Group Ltd. manages 11 pathology laboratories. The company is based in Queenstown, New Zealand. New Zealand Diagnostics Group was acquired by Healthscope Operations Pty Ltd. on December 18, 2007. | Finanzdirektor/CFO | 07.06.2011 |
Ehemalige bekannte Positionen von Chris Coombe
Unternehmen | Position | Ende |
---|---|---|
ZESPRI International Ltd. (United States)
![]() ZESPRI International Ltd. (United States) Food DistributorsDistribution Services ZESPRI International Ltd. grows and sells kiwifruits. Its products include sungold kiwifruit pavlova parfaits, baked brie with spicy kiwifuit compote and panna cotta with fresh kiwifruit coulis. The company was founded in 1904 is headquartered in Newport Beach, CA. | Corporate Officer/Principal | - |
AIR NEW ZEALAND LIMITED | Vertrieb & Marketing | - |
eBonz Ltd.
![]() eBonz Ltd. Pharmaceuticals: OtherHealth Technology eBonz was a startup company from the Auckland Bioengineering Institute involved in the development of functional 3D anatomically based models of the joints in the human body. eBonz develop patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. These models can be used by orthopedic device and insurance companies, and for education and training of patients and surgeons. eBonz was established in 2007 to take orthopedic modeling to market. It was built upon extensive research at the Auckland Bioengineering Institute (ABI) in the field of computational biomechanics. The ABI has an international reputation for innovative research and successful commercialization of ideas. eBonz continues to have a very close working relationship with the ABI. eBonz developed patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. | Corporate Officer/Principal | - |
Ausbildung von Chris Coombe
Auckland University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
AIR NEW ZEALAND LIMITED | Transportation |
Private Unternehmen | 3 |
---|---|
New Zealand Diagnostics Group Ltd.
![]() New Zealand Diagnostics Group Ltd. Medical/Nursing ServicesHealth Services Part of Healthscope Operations Pty Ltd., New Zealand Diagnostics Group Ltd. manages 11 pathology laboratories. The company is based in Queenstown, New Zealand. New Zealand Diagnostics Group was acquired by Healthscope Operations Pty Ltd. on December 18, 2007. | Health Services |
ZESPRI International Ltd. (United States)
![]() ZESPRI International Ltd. (United States) Food DistributorsDistribution Services ZESPRI International Ltd. grows and sells kiwifruits. Its products include sungold kiwifruit pavlova parfaits, baked brie with spicy kiwifuit compote and panna cotta with fresh kiwifruit coulis. The company was founded in 1904 is headquartered in Newport Beach, CA. | Distribution Services |
eBonz Ltd.
![]() eBonz Ltd. Pharmaceuticals: OtherHealth Technology eBonz was a startup company from the Auckland Bioengineering Institute involved in the development of functional 3D anatomically based models of the joints in the human body. eBonz develop patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. These models can be used by orthopedic device and insurance companies, and for education and training of patients and surgeons. eBonz was established in 2007 to take orthopedic modeling to market. It was built upon extensive research at the Auckland Bioengineering Institute (ABI) in the field of computational biomechanics. The ABI has an international reputation for innovative research and successful commercialization of ideas. eBonz continues to have a very close working relationship with the ABI. eBonz developed patient specific models of the musculo-skeletal system to allow better surgical planning and customized implant design. | Health Technology |